I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Randomized phase 2 study of FcRn antagonist efgartigimod in..:
Howard, James F
;
Bril, Vera
;
Burns, Ted M
...
qt4ws1d83j. , 2019
Link:
https://escholarship.org/uc/item/4ws1d83j
RT Journal T1
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt4ws1d83j&Exemplar=1&LAN=DE A1 Howard, James F A1 Bril, Vera A1 Burns, Ted M A1 Mantegazza, Renato A1 Bilinska, Malgorzata A1 Szczudlik, Andrzej A1 Beydoun, Said A1 Garrido, Francisco Javier Rodriguez De Rivera A1 Piehl, Fredrik A1 Rottoli, Mariarosa A1 Van Damme, Philip A1 Vu, Tuan A1 Evoli, Amelia A1 Freimer, Miriam A1 Mozaffar, Tahseen A1 Ward, E Sally A1 Dreier, Torsten A1 Ulrichts, Peter A1 Verschueren, Katrien A1 Guglietta, Antonio A1 de Haard, Hans A1 Leupin, Nicolas A1 Verschuuren, Jan JGM PB eScholarship, University of California YR 2019 K1 Clinical Trials and Supportive Activities K1 Clinical Research K1 Myasthenia Gravis K1 Neurosciences K1 Rare Diseases K1 Autoimmune Disease K1 Evaluation of treatments and therapeutic interventions K1 6.1 Pharmaceuticals K1 Activities of Daily Living K1 Adrenal Cortex Hormones K1 Adult K1 Aged K1 Autoantibodies K1 Cholinesterase Inhibitors K1 Double-Blind Method K1 Female K1 Histocompatibility Antigens Class I K1 Humans K1 Immunoglobulin Fc Fragments K1 Immunologic Factors K1 Immunosuppressive Agents K1 Male K1 Middle Aged K1 Receptors K1 Cholinergic K1 Fc K1 Treatment Outcome K1 Young Adult K1 Efgartigimod MG Study Group K1 Clinical Sciences K1 Cognitive Sciences K1 Neurology & Neurosurgery JF qt4ws1d83j LK http://dx.doi.org/https://escholarship.org/uc/item/4ws1d83j DO https://escholarship.org/uc/item/4ws1d83j SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)